What is Agios Pharmaceuticals's R&D?

Agios Pharmaceuticals (AGIO) reported R&D of $81.15M in Q1 2026.

How has Agios Pharmaceuticals's R&D changed year-over-year?

Agios Pharmaceuticals's R&D increased by 11.6% year-over-year, from $72.74M to $81.15M.

What is the long-term trend for Agios Pharmaceuticals's R&D?

Over 4 years (2021 to 2025), Agios Pharmaceuticals's R&D has grown at a 7.2% compound annual growth rate (CAGR), from $256.97M to $339.54M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Agios Pharmaceuticals AGIO R&D

R&D at other companies

Bristol-Myers SquibbBMY

$2.65B+17.4%

IncyteINCY

$515.9M+18.0%

BioMarin PharmaceuticalsBMRN

$178.8M+12.6%

Disc MedicineIRON

$45.9M+65.3%

PrecigenPGEN

$5.64M-46.2%

Ultragenyx PharmaceuticalRARE

$187M+12.7%

Segments

By segment

See full

Reportable Segment$23.91M+12.1%

Other financials

Income statement

See full

Revenue$20.7M+138%

Gross profit$19.4M+154%

Operating income-$110.0M-3.2%

Net income-$99.1M-11.0%

EPS (diluted)-$1.69-9.0%

Balance sheet

See full

Cash & equivalents$113.6M+43.9%

Total debt$35.7M-32.5%

Total equity$1.1B-24.4%

Total assets$1.2B-23.8%

Cash flow

See full

Operating cash flow-$118.9M-6.7%

CapEx$769.0K+0.4%

Free cash flow-$119.7M-6.6%

Valuation

See full

Market cap$2.12B+18.1%

Enterprise value$2.04B+15.2%

P/S32.1×-16.4×

Profitability

See full

Gross margin90%+2.5pp

Operating margin-720%-204pp

Net margin-639.8%—

FCF margin-582.5%-185pp

Returns & leverage

See full

Return on equity-32.8%—

Debt / equity0×0.0×

Current ratio14.2×-4.3×

Where this comes from

Reported directly by Agios Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agios Pharmaceuticals's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Agios Pharmaceuticals's R&D?: Agios Pharmaceuticals (AGIO) reported R&D of $81.15M in Q1 2026.
How has Agios Pharmaceuticals's R&D changed year-over-year?: Agios Pharmaceuticals's R&D increased by 11.6% year-over-year, from $72.74M to $81.15M.
What is the long-term trend for Agios Pharmaceuticals's R&D?: Over 4 years (2021 to 2025), Agios Pharmaceuticals's R&D has grown at a 7.2% compound annual growth rate (CAGR), from $256.97M to $339.54M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.